Sildenafil Tablet, Film Coated
Product Images NDC 68071-3743

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-3743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3743 3)

Label for Sildenafil 50 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The prescription drug label shows a 30-count package with a drug facts panel indicating each tablet contains Sildenafil Citrate USP equivalent to 50 mg Sildenafil. The label includes NDC 68071-3743-3 and storage instructions at controlled temperature 68-77°F. It also includes warnings to keep out of reach of children, barcode, lot and expiration date placeholders, and distributor information.*

FDA Label Image

Figure 1 (Sildenafil Fig1)

A line graph showing mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers, comparing Sildenafil 100 mg to placebo. The x-axis represents time post dose in hours, and the y-axis represents change in systolic blood pressure (mmHg). Sildenafil shows a consistent decrease, while placebo varies above and below baseline.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

A line graph depicting the mean standing systolic blood pressure (SBP) change from baseline over an 8-hour period. It compares two groups: one receiving Doxazosin plus placebo and the other Doxazosin plus Sildenafil 25 mg. The y-axis shows change in SBP in mmHg; the x-axis shows time postdose in hours.*

FDA Label Image

Figure 3 (Sildenafil Fig3)

A line graph showing the mean standing systolic blood pressure change from baseline over 8 hours postdose. It compares two groups: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg, with the y-axis representing change in SBP (mmHg) and the x-axis representing time postdose (hours).*

FDA Label Image

Figure 4 (Sildenafil Fig4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' depicting blood pressure changes in mmHg over 8 hours after dosing. It compares two groups: one receiving Doxazosin plus Sildenafil 100 mg and the other receiving Doxazosin plus Placebo, showing fluctuations in systolic blood pressure over time.*

FDA Label Image

Figure 5 (Sildenafil Fig5)

Line graph showing mean sildenafil plasma concentrations (ng/mL) over 24 hours post dose in healthy male volunteers using a commercial tablet. The y-axis represents plasma concentrations, peaking early around 450 ng/mL, then steadily declining to near zero by 24 hours. The x-axis represents time in hours post dose from 0 to 24.*

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

Two bar charts illustrating the effect of Sildenafil and placebo on maintenance of erection by baseline score. The vertical axis shows the percentage of patients at endpoint, and the horizontal axis shows baseline scores from 0 to 5. Different shading in the bars corresponds to maintenance scores ranging from 0 to 5 for each baseline score.*

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

A vertical bar graph illustrating the percentage of patients reporting improvement in erections across four treatment groups: Placebo, Sildenafil 25 mg, Sildenafil 50 mg, and Sildenafil 100 mg. The percentages increase from placebo to the highest dose of Sildenafil. The graph highlights a treatment effect trend with higher doses showing greater improvement.*

FDA Label Image

Structure (Sildenafil Str)

Chemical structure diagram of Sildenafil, showing its molecular components and arrangement, corresponding to its chemical composition as represented in the product data.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.